Eliquis, Jakavi added to green list in April

Published: 2013-04-30 06:57:00

Updated: 2013-04-30 06:57:00

Several original brands, including BMS-Pfizer’s Equiquis and Novartis’s Jakavi and Boehringer Ingelheim’s Trajenta, were added to a list of patents associated with drug products in April, the Ministry of Food and Drug Safety (MFDS) said Monday.

Included also in the list were Mundipharma’s Lodo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK